Literature DB >> 6342642

Anti-inflammatory (ibuprofen) drug therapy in rheumatoid arthritis--rate of response and lack of time dependency of plasma pharmacokinetics.

L Aarons, D M Grennan, C Rajapakse, J Brinkley, M Siddiqui, L Taylor, C Higham.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6342642      PMCID： PMC1427784          DOI： 10.1111/j.1365-2125.1983.tb01517.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  5 in total

1.  1958 REVISION of diagnostic criteria for rheumatoid arthritis.

Authors: 
Journal:  Arthritis Rheum       Date:  1959-02

2.  Measurement of pain.

Authors:  E C Huskisson
Journal:  Lancet       Date:  1974-11-09       Impact factor: 79.321

3.  Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis.

Authors:  D M Ritchie; J A Boyle; J M McInnes; M K Jasani; T G Dalakos; P Grieveson; W W Buchanan
Journal:  Q J Med       Date:  1968-07

4.  A chronic dose-ranging study of the pharmacokinetics of phenylbutazone in rheumatoid arthritic patients.

Authors:  C Higham; L Aarons; P J Holt; M Lynch; M Rowland
Journal:  Br J Clin Pharmacol       Date:  1981-08       Impact factor: 4.335

5.  Treatment of rheumatoid arthritis with fenoprofen: comparison with aspirin.

Authors:  E C Huskisson; J A Wojtulewski; H Berry; J Scott; F D Hart; H W Balme
Journal:  Br Med J       Date:  1974-02-02
  5 in total
  7 in total

1.  A review of non-steroidal anti-inflammatory drugs.

Authors:  D Rosenbloom; M A Craven
Journal:  Can Fam Physician       Date:  1983-11       Impact factor: 3.275

2.  Stereoselective drug disposition: potential for misinterpretation of drug disposition data.

Authors:  A M Evans; R L Nation; L N Sansom; F Bochner; A A Somogyi
Journal:  Br J Clin Pharmacol       Date:  1988-12       Impact factor: 4.335

3.  Intra-uterine pressure and serum ibuprofen: observations after oral administration of 400 mg ibuprofen to a patient with primary dysmenorrhoea.

Authors:  I Milsom; B Andersch
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

Review 4.  Clinical pharmacokinetics of ibuprofen. The first 30 years.

Authors:  N M Davies
Journal:  Clin Pharmacokinet       Date:  1998-02       Impact factor: 6.447

5.  Variability in response to nonsteroidal anti-inflammatory analgesics: evidence from controlled clinical therapeutic trial of flurbiprofen in rheumatoid arthritis.

Authors:  S J Preston; M H Arnold; E M Beller; P M Brooks; W W Buchanan
Journal:  Br J Clin Pharmacol       Date:  1988-12       Impact factor: 4.335

6.  Dose-response study with ibuprofen in rheumatoid arthritis: clinical and pharmacokinetic findings.

Authors:  D M Grennan; L Aarons; M Siddiqui; M Richards; R Thompson; C Higham
Journal:  Br J Clin Pharmacol       Date:  1983-03       Impact factor: 4.335

7.  Pharmacokinetics of S(+)- and R(-)-ibuprofen in volunteers and first clinical experience of S(+)-ibuprofen in rheumatoid arthritis.

Authors:  G Geisslinger; O Schuster; K P Stock; D Loew; G L Bach; K Brune
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.